BCG versus epirubicin in the prophylaxis of multiple superficial bladder tumours: results of a prospective randomized study using modified treatment schemes (Q73269837)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1996

Language	Label	Description	Also known as
English	BCG versus epirubicin in the prophylaxis of multiple superficial bladder tumours: results of a prospective randomized study using modified treatment schemes	scientific article published on 01 January 1996

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

BCG versus epirubicin in the prophylaxis of multiple superficial bladder tumours: results of a prospective randomized study using modified treatment schemes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M D Melekos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I Zarakovitis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Dandinis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Fokaefs

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Chionis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Dauaher

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Barbalias

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

499-509

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An overview of intravesical therapy for superficial bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 1/2 study of intravesical epirubicin in patients with carcinoma in situ of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instill

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4'-Epidoxorubicin versus Mitomycin C Intravesical Chemoprophylaxis of Superficial Bladder Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacillus Calmette-Guérin immunotherapy. Techniques and results

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical bacillus Calmette-Guérin administration in the prophylaxis of superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical Bacillus Calmette-Guérin prophylactic treatment for superficial bladder tumors: results of a controlled prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary ca

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The site of recurrence of non-infiltrating bladder tumours.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maximum utilization of the life table method in analyzing survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical chemotherapy with 4'-epi-Adriamycin in patients with superficial bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BCG in perspective: advances in the treatment of superficial bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylaxis of superficial bladder cancer with a modified intravesical epirubicin treatment schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical Instillations of 4-EPI-Doxorubicin (Epirubicin) in the Prophylactic Treatment of Superficial Bladder Cancer: Results of a Controlled Prospective Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The place of intravesical chemotherapy as defined by results of prospective randomized studies (substances and treatment schemes)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/9119635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02550957

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73269837&oldid=2204827223"